journal article·2018-11-14

In Vivo Laser-Mediated Retinal Ganglion Cell Optoporation Using KV1.1 Conjugated Gold Nanoparticles

Ariel M. Wilson, Javier Mazzaferri, Éric Bergeron, Sergiy Patskovsky, Paule Marcoux-Valiquette, Santiago Costantino, Przemyslaw Sapieha, Michel Meunier

Nano Letters· Volume 18· Issue 11
Publisher page

Abstract

Vision loss caused by retinal diseases affects hundreds of millions of individuals worldwide. The retina is a delicate central nervous system tissue stratified into layers of cells with distinct roles. Currently, there is a void in treatments that selectively target diseased retinal cells, and current therapeutic paradigms present complications associated with off-target effects. Herein, as a proof of concept, we introduce an in vivo method using a femtosecond laser to locally optoporate retinal ganglion cells (RGCs) targeted with functionalized gold nanoparticles (AuNPs). We provide evidence that AuNPs functionalized with an antibody toward the cell-surface voltage-gated K+ channel subunit KV1.1 can selectively deliver fluorescently tagged siRNAs or fluorescein isothiocyanate-dextran dye into retinal cells when irradiated with an 800 nm 100 fs laser. Importantly, neither AuNP administration nor irradiation resulted in RGC death. This system provides a novel, non-viral-based approach that has the potential to selectively target retinal cells in diseased regions while sparing healthy areas and may be harnessed in future cell-specific therapies for retinal degenerative diseases.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Retinal Development and Disorders · Photoreceptor and optogenetics research · Neuroscience and Neural Engineering

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Engineering Physics, Polytechnique Montréal, Montreal, Quebec, Canada, H3C 3A7

Funding

Government of Canada · Foundation Fighting Blindness · Canada Research Chairs · Canadian Diabetes Association · Heart and Stroke Foundation of Canada · Consortium Quebecois sur la Decouverte du Medicament

References (61)

Show source-provided references
1. 10.1001/jamaophthalmol.2016.262710.1001/jamaophthalmol.2016.2627 ↗
2. 10.1016/j.ophtha.2014.05.01310.1016/j.ophtha.2014.05.013 ↗
3. Medical Letter on Drugs & Therapeutics · 2018 · 60 · 53
4. 10.1016/j.exer.2011.07.00110.1016/j.exer.2011.07.001 ↗
5. 10.1038/mt.2012.28010.1038/mt.2012.280 ↗
6. 10.3129/i07-04910.3129/i07-049 ↗
7. 10.1167/iovs.16-2078610.1167/iovs.16-20786 ↗
8. 10.1136/bjophthalmol-2013-30388510.1136/bjophthalmol-2013-303885 ↗
9. 10.1016/j.biomaterials.2011.11.06210.1016/j.biomaterials.2011.11.062 ↗
10. 10.1039/C5NR05650K10.1039/C5NR05650K ↗
11. Ding W. · 2015 · 33110.1533/9781908818782.331 ↗
12. 10.1016/j.jphotochemrev.2013.06.00110.1016/j.jphotochemrev.2013.06.001 ↗
13. 10.1186/s12951-014-0057-110.1186/s12951-014-0057-1 ↗
14. 10.1021/nl302200w10.1021/nl302200w ↗
15. 10.1039/C6NR08773F10.1039/C6NR08773F ↗
16. 10.1002/jbio.20150013510.1002/jbio.201500135 ↗
17. 10.1039/C5NR02721G10.1039/C5NR02721G ↗
18. 10.1038/8668410.1038/86684 ↗
19. 10.1039/C6NR01257D10.1039/C6NR01257D ↗
20. 10.1021/acsphotonics.6b0065210.1021/acsphotonics.6b00652 ↗
21. 10.1021/acs.nanolett.6b0056210.1021/acs.nanolett.6b00562 ↗
22. 10.1016/j.preteyeres.2013.04.00110.1016/j.preteyeres.2013.04.001 ↗
23. 10.1371/journal.pone.004983010.1371/journal.pone.0049830 ↗
24. 10.1167/iovs.08-326710.1167/iovs.08-3267 ↗
25. 10.1002/cne.2352110.1002/cne.23521 ↗
26. 10.1016/0306-4522(84)90195-710.1016/0306-4522(84)90195-7 ↗
27. 10.1167/iovs.09-409810.1167/iovs.09-4098 ↗
28. 10.1016/j.brainres.2007.07.09010.1016/j.brainres.2007.07.090 ↗
29. 10.1038/340035a010.1038/340035a0 ↗
30. 10.1073/pnas.83.12.432710.1073/pnas.83.12.4327 ↗
31. 10.1002/(SICI)1096-9861(20000529)421:2<215::AID-CNE7>3.0.CO;2-U10.1002/(SICI)1096-9861(20000529)421:2<215::AID-CNE7>3.0.CO;2-U ↗
32. 10.1002/jnr.2110510.1002/jnr.21105 ↗
33. 10.1039/C6NR01257D10.1039/C6NR01257D ↗
34. 10.1016/j.biomaterials.2013.04.03510.1016/j.biomaterials.2013.04.035 ↗
35. 10.1007/s11095-008-9745-610.1007/s11095-008-9745-6 ↗
36. 10.1016/j.biomaterials.2012.01.03010.1016/j.biomaterials.2012.01.030 ↗
37. 10.1002/jbio.20140002510.1002/jbio.201400025 ↗
38. 10.2174/187436410100401005210.2174/1874364101004010052 ↗
39. 10.1111/j.1476-5381.1984.tb10760.x10.1111/j.1476-5381.1984.tb10760.x ↗
40. 10.1016/0014-4835(86)90026-610.1016/0014-4835(86)90026-6 ↗
41. 10.1073/pnas.090927610710.1073/pnas.0909276107 ↗
42. 10.1523/JNEUROSCI.2635-12.201310.1523/JNEUROSCI.2635-12.2013 ↗
43. 10.1089/neu.1999.16.15310.1089/neu.1999.16.153 ↗
44. 10.1167/iovs.10-673810.1167/iovs.10-6738 ↗
45. 10.1172/jci.insight.12155510.1172/jci.insight.121555 ↗
46. 10.1364/BOE.7.00514810.1364/BOE.7.005148 ↗
47. 10.1073/pnas.141016211110.1073/pnas.1410162111 ↗
48. 10.1038/3588810.1038/35888 ↗
49. 10.1096/fj.00-0598fje10.1096/fj.00-0598fje ↗
50. 10.1371/journal.pone.000355410.1371/journal.pone.0003554 ↗
51. 10.1001/archopht.1995.0110012006801210.1001/archopht.1995.01100120068012 ↗
52. Hirsch L. R. · 2005 · 303 · 10110.1385/1-59259-901-X:101 ↗
53. 10.1002/jbio.20130016510.1002/jbio.201300165 ↗
54. 10.1002/jbio.20140002510.1002/jbio.201400025 ↗
55. 10.1021/la301390u10.1021/la301390u ↗
56. 10.1038/protex.2011.21510.1038/protex.2011.215 ↗
57. 10.1167/iovs.10-687310.1167/iovs.10-6873 ↗
58. 10.1172/JCI3381310.1172/JCI33813 ↗
59. 10.1172/JCI3169210.1172/JCI31692 ↗
60. Pang J.-J. · Molecular vision · 2005 · 11 · 152
61. 10.1002/jnr.2080310.1002/jnr.20803 ↗